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Background/Aims: Reports of the prevalence of and trends in metabolic syndrome in Korea have been inconsistent. 
Thus, we investigated the reasons underlying these inconsistencies.
Methods: We estimated the prevalence of metabolic syndrome using different diagnostic criteria, exclusion criteria, and 
sampling weights among 5,509 respondents, aged 20-79, who participated in the 2001 Korean National Health and 
Nutrition Examination Surveys (KNHANES). Trends in metabolic syndrome were assessed by examining the 1998 (n = 
6,747), 2001 (n = 4,337), and 2005 (n = 5,139) KNHANES.
Results: The estimated prevalence of metabolic syndrome in 2001 ranged from 1.6 to 29.6% in males and from 10.1 
to 32.8% in females, depending on the diagnostic criteria used. The exclusion criteria and sampling weights did not 
significantly affect the prevalence estimates. The prevalence of metabolic syndrome first significantly increased and then 
decreased between 1998, 2001, and 2005 in males (26.2, 29.6, and 27.2%, respectively) and females (29.2, 32.8, and 
24.7%, respectively). Among the individual metabolic variables, triglyceride levels in 2001 were significantly higher than 
in 1998 and 2005, whereas other variables remained relatively constant during the same period. The exceptionally high 
triglyceride levels in 2001 might have contributed to the increased prevalence of metabolic syndrome between 1998 and 
2001.
Conclusions: Different diagnostic criteria for metabolic syndrome represent a major cause of the inconsistent estimates of 
prevalence, and the absence of standardized laboratory methods might have affected the trend estimates.
Keywords: Metabolic syndrome; Prevalence; Trends; Epidemiology; Korea 
INTRODUCTION
   
Metabolic syndrome refers to a cluster of several car-
diovascular risk factors most commonly including obesity, 
type 2 diabetes, dyslipidemia, and hypertension [1]. Due 
to increasing consumption of high-fat diets and decreas-
ing physical activity, obesity has become more prevalent 
in Korea. Consequently, the prevalence of metabolic syn-
drome is also expected to increase [2]. However, projec-
tions of prevalence of and trends in metabolic syndrome 
in Korea have been inconsistent. Prevalence estimates of 
metabolic syndrome vary widely, from 5.2 to 35.3% for 
men and 9.0 to 39.2% for women [2-18]. Although some 
inconsistencies may be due to differences in study popu-
lation and design [3-9], even studies analyzing the same 
data have reported inconsistent prevalence and trend esti-
Copyright © 2011 The Korean Association of Internal Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Received : March 3, 2009
Revised   : july 11, 2011
Accepted : july 21, 2011
Correspondence to Hyeon Chang Kim, M.D.
Department of Preventive Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea
Tel: 82-2-2228-1873, Fax: 82-2-392-8133, E-mail: hckim@yuhs.acKim HC and Kim Dj. Causes of different prevalence of metabolic syndrome     441
http://dx.doi.org/10.3904/kjim.2011.26.4.440 http://www.kjim.or.kr
mates (Table 1) [2,10-18]. For example, using data from the 
Korea National Health and Nutrition Examination Sur-
vey (KNHANES), one study reported a rapid increase of 
metabolic syndrome between 1998 and 2001 [14], whereas 
another reported no increase during the same period 
[15]. Different estimates of prevalence or trajectories of 
metabolic syndrome can create confusion not only for the 
public but also among health care professionals. Indeed, 
it is impossible to identify a single study to represent the 
best approach to assessing metabolic syndrome in Korea 
because each involves unique objectives and rationales 
for the methodologies employed. Thus, it is important to 
consider the potential causes of different estimates when 
reporting and interpreting data on the prevalence and tra-
jectory of metabolic syndrome. The purpose of this study 
was to assess the effect of different diagnostic and exclu-
sion criteria and different statistical methods on estimates 
of the prevalence of metabolic syndrome.
METHODS
This study analyzed findings from the KNHANES, 
which was conducted by the Korean Ministry of Health 
and Welfare in 1998, 2001, and 2005. The KNHANES 
consisted of a health interview, medical examinations, 
and nutrition surveys. A stratified multistage probabil-
ity sampling design was used, with selection made from 
sampling units based on geographical area and type 
of residence. In the present study, the effects of differ-
ent diagnostic criteria, exclusion criteria, and statistical 
methods were assessed using the 2001 KNHANES data. A 
total of 5,509 (2,349 males and 3,160 females) individuals 
aged 20 to 79 years completed health examinations for the 
2001 KNHANES. Of these, 490 males and 644 females 
had not fulfilled the fasting requirements (8 hours) when 
their blood samples were taken, and 43 females (includ-
ing five excluded due to the fasting requirement) were 
currently pregnant. To compare the prevalence of meta-
bolic syndrome in the different survey years, we analyzed 
Table 1. Prevalence of metabolic syndrome based on the 1998 and 2001 Korea National Health and Nutrition Exami-
nation Surveys (KNHANES)
Study Ages Definition
WC cutoff, cm 
(men/women)
Prevalence in the 1998 KNHANES, % Prevalence in the 2001 KNHANES, %
Total Men Women Total Men Women
Yoon et al. [10] ≥ 20 NCEP  90/80   20.8 26.9
Kim et al. [11] ≥ 25 NCEP  90/80   22.1 27.8
Park et al. [12] 20-79 NCEP 102/88   14.2 17.7
Park et al. [13] 20-80 IDF  90/85   13.5 15.0
Lim et al. [14] ≥ 20 NCEP 102/88   17.3 20.0
NCEP  90/80   23.6 28.0
Park et al. [15] ≥ 20 NCEP 102/88   15.7 13.7 17.8 14.4 13.0 16.2
NCEP  90/80   21.6 19.4 23.9 21.4 20.1 23.4
Park et al. [2] ≥ 20 NCEP 102/88   17.2 15.0 19.5 17.6 17.4 18.2
NCEP 90/80   28.3 25.9 30.9 30.9 30.7 31.6
IDF 90/80   14.9 13.8 16.1 16.2 17.4 18.2
Choi et al. [16] ≥ 20 NCEP 102/88   18.8 17.8 20.5
IDF 102/88   19.5 15.0 23.9
Kim et al. [17] ≥ 20 NCEP  90/85   23.7 24.6 23.0
NCEP  90/80   26.7 24.6 28.1
IDF  90/85   17.5 16.5 18.2
IDF  90/80   23.8 16.5 28.8
Park et al. [18] 20-79 NCEP 102/88   - 23.2 24.8
NCEP  90/85   29.0 31.0 27.6
WC, waist circumference; NCEP, National Cholesterol Education Program-Adult Treatment Panel III; IDF, International Diabetes 
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data obtained from all subjects who met fasting and non-
pregnant criteria in each survey: 6,747 (3,054 males and 
3,693 females) participants in the 1998 KNHANES, 4,337 
(1,850 males and 2,478 females) participants in the 2001 
KNHANES, and 5,139 (2,204 males and 2,935 females) 
participants in the 2005 KNHANES.
Waist circumference was measured to the nearest 0.1 
cm at the midpoint between the lower borders of the rib 
cage and the iliac crest. Systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) were measured using a 
standard mercury sphygmomanometer at phase I and V 
Korotkoff sounds, respectively. At least two SBP and DBP 
readings were recorded, and their averages were used for 
analysis. Blood samples were taken after an overnight 
fasting period and then analyzed at a central certified 
laboratory to determine serum concentrations of fasting 
glucose, total cholesterol, triglycerides, and high-density 
lipoprotein (HDL)-cholesterol using an autoanalyzer 
(Hitachi 747, Tokyo, Japan). Medical history and current 
medication status were ascertained via self-administered 
questionnaires.
The definition of metabolic syndrome was based on 
the those of the National Cholesterol Education Program 
(NCEP) Adult Treatment Panel III [19] and the Interna-
tional Diabetes Federation (IDF) [20], including variously 
modified cutoff points. Individuals demonstrating three or 
more of the following five abnormalities were diagnosed 
by the NCEP with metabolic syndrome, and those who 
met the criteria for central obesity plus two or more other 
abnormalities were diagnosed with metabolic syndrome 
by the IDF. Central obesity was defined as waist circumfer-
ence > 102 cm or > 90 cm  for men and > 88 cm, > 85 cm, 
or > 80 cm for women. High fasting glucose was defined 
as ≥ 110 mg/dL or ≥ 100 mg/dL by the NCEP, but as only ≥ 
100 mg/dL by the IDF. Low HDL-cholesterol was defined 
as < 40 mg/dL for men and < 50 mg/dL or < 40 mg/dL for 
women. High blood pressure (SBP ≥ 130 mmHg or DBP ≥ 
85 mmHg), and high triglycerides (≥ 150 mg/dL) were uni-
formly defined. Participants receiving anti-hypertensive or 
anti-diabetic medications were considered as having high 
blood pressure or high fasting glucose, respectively. Infor-
mation on medications specific for elevated triglycerides 
and reduced HDL-cholesterol was unavailable.
All statistical analyses were conducted using SAS ver-
sion 9.12 (SAS Institute Inc., Cary, NC, USA), taking into 
account the sampling weights unless otherwise indicated. 
The prevalence of metabolic syndrome and its 95% con-
fidence interval (CI) were calculated using the varying 
definitions of the syndrome. In this analysis, individu-
als who fasted for < 8 hours or who were pregnant were 
excluded, and the sampling weights were adjusted taking 
into consideration the different exclusion rates by sex and 
age. Age-specific prevalence was calculated both with and 
without consideration of the sampling weights, and both 
including and excluding inappropriate subjects to assess 
the effects of sampling weights and exclusion criteria. For 
this analysis, metabolic syndrome was defined accord-
ing to the revised NCEP definition with modified waist 
circumference cutoff points (> 90 cm for males; > 80 cm 
females). Results of the 1998, 2001, and 2005 KNHANES 
were compared in terms of individual metabolic variables 
and the combined metabolic syndrome. The median and 
inter-quartile ranges of each metabolic variable and the 
prevalence of metabolic syndrome were obtained for each 
survey year. To assess the impact of year-to-year variabil-
ity in triglyceride levels on the prevalence estimation, we 
calculated the prevalence of metabolic syndrome using 
both absolute and relative criteria for elevated triglycer-
ides. The absolute criterion was triglycerides ≥ 150 mg/
dL in all three years, and the relative criterion was the sex-
specific highest quartile value in each survey.
RESULTS
The prevalence of metabolic syndrome varied widely 
according to the particular definition and modified cutoff 
points for individual metabolic abnormalities (Table 2). 
The highest prevalence was 29.6% (95% CI, 27.4 to 31.7) in 
males and 32.8% (95% CI, 30.9 to 34.7) in females when 
we used the modified NCEP definition with the Asian-
specific waist circumference cutoff (> 90/80 cm for men/
women). Sampling weights and exclusion criteria did not 
significantly affect the prevalence. In a subgroup of 60-69 
years old the prevalence of metabolic syndrome differed 
by 1.7% between unweighted and weighted estimates, but 
this was not significant (Table 3).
We compared the distributions of individual metabolic 
variables and prevalence of metabolic syndrome in 1998, 
2001, and 2005 (Table 4). Distributions of waist circumfer-
ence and blood pressure remained relatively stable during 
this period. Fasting triglyceride levels increased by 11 mg/Kim HC and Kim Dj. Causes of different prevalence of metabolic syndrome     443
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dL in males and by 7 mg/dL in females between 1998 and 
2001, but decreased by 8 mg/dL in males and by 12 mg/
dL in females between 2001 and 2005. HDL-cholesterol 
and fasting glucose levels decreased continuously between 
1998 and 2005. The prevalence of metabolic syndrome 
significantly increased between 1998 and 2001 in both 
males (26.2-29.6%; p = 0.015) and females (29.2-32.8%; 
p = 0.004). In 2005, the prevalence in males decreased to 
a level similar to that of 1998 (27.2%; p = 0.469), and the 
prevalence among women fell to a level below that in 1998 
(24.7%; p < 0.001). However, when the relative criteria de-
fined above were used to establish elevated triglycerides, 
no significant change in prevalence between 1998 and 
2001 was found, and the decrease between 2001 and 2005 
was limited to females.
DISCUSSION
Currently, the most common definitions of metabolic 
syndrome include that proposed by the NCEP [19], its 
revised version developed by the American Heart As-
sociation and the National Heart, Lung, and Blood In-
stitute (revised NCEP) [21], and the definition proposed 
by the IDF [20]. These three have been commonly used 
in Korean studies, with some modifications for Korean 
populations. Lowered waist circumference cutoff points 
represent the most common modification, based on the 
fact that Asians are more vulnerable than Caucasians to 
cardiovascular disease at a given level of obesity [22,23]. 
However, Korean data showing the risk for cardiovascular 
diseases at different waist circumferences are limited, and 
a standard definition of central obesity for Koreans has 
not yet been established [24]. The original NCEP defini-
tion placed the waist circumference cutoff point at 102/88 
cm (for males/females), and it has since been lowered to 
90/80 cm [20,21,25] or 90/85 cm [26] for male/female 
Asians. Our results showed that those modifications sig-
nificantly changed the estimated prevalence of metabolic 
syndrome (Table 2). Modified waist-circumference cutoff 
Table 2. Prevalence of metabolic syndrome in the 2001 Korea National Health and Nutrition Examination Surveys 
(KNHANES) with modified cutoff levels
Sex
Modified cutoff level Prevalence (95% CI) of metabolic syndrome
WC, cm FBS, mg/dL HDLC, mg/dL By NCEP definition, % By IDF definition, %
Men > 102 ≥ 110 < 40 16.8 (15.1-18.6)
> 102 ≥ 100 < 40 23.2 (21.3-25.2)   1.6 (1.0-2.1)
> 90 ≥ 110 < 40 23.7 (21.8-25.7)
> 90 ≥ 100 < 40 29.6 (27.4-31.7)   15.9 (14.2-17.6)
Women > 88 ≥ 110 < 40 13.5 (12.1-14.9)
> 88 ≥ 110 < 50 19.0 (17.4-20.6)
> 88 ≥ 100 < 40  17.1 (15.6-18.6)  10.1 (8.8-11.3)
> 88 ≥ 100 < 50  24.2 (22.5-26.0)   11.8 (10.5-13.1)
> 85 ≥ 110 < 40 15.2 (13.8-16.7)
> 85 ≥ 110 < 50 21.7 (20.1-23.4)
> 85 ≥ 100 < 40 19.4 (17.8-21.0)   14.0 (12.5-15.4)
> 85 ≥ 100 < 50 26.9 (25.1-28.7)    17.1 (15.6-18.6)
> 80 ≥ 110 < 40 18.6 (17.0-20.2)
> 80 ≥ 110 < 50  26.5 (24.8-28.3)
> 80 ≥ 100 < 40 23.9 (22.1-25.6)    21.2 (19.5-22.8)
> 80 ≥ 100 < 50  32.8 (30.9-34.7)    27.3 (25.5-29.1)
Cutoff points for high blood pressure (systolic blood pressure/diastolic blood pressure ≥ 130/85 mmHg) and elevated triglyceride (≥ 150 
mg/dL) are constant.
WC, waist circumference; FBS, fasting blood glucose; HDLC, high-density lipoprotein cholesterol; CI, confidence interval; NCEP, 
National Cholesterol Education Program-Adult Treatment Panel III; IDF, International Diabetes Federation.444    The Korean journal of Internal Medicine Vol. 26, No. 4, December 2011
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points especially affect the prevalence of metabolic syn-
drome based on the IDF definition because this definition 
requires central obesity as an essential component for the 
diagnosis of the syndrome [20]. When we used the revised 
NCEP definition, lowering the waist circumference cutoff 
points from 102/88 to 90/80 cm increased the prevalence 
of metabolic syndrome from 23.2 to 29.6% for males and 
from 24.2 to 32.8% for females. When we used the IDF 
definition, the same modification caused a much larger in-
crease: from 1.6 to 15.9% for males and from 11.8 to 27.3% 
for females. Thus, it is important to pay special attention 
to the diagnosis of central obesity when evaluating reports 
on the prevalence of metabolic syndrome.
Elevated fasting glucose has been defined as both ≥ 110 
and ≥ 100 mg/dL. Lowered cutoff points might increase 
the metabolic syndrome prevalence estimates by more 
than 5%. However, as both the revised NCEP and the IDF 
definitions suggested a threshold of 100 mg/dL [20,21], 
most recent studies have defined an elevated fasting glu-
cose as 100 mg/dL or higher. The cutoff point for reduced 
HDL-cholesterol represents an additional issue. Although 
Koreans have a relatively low prevalence of obesity, the 
prevalence of metabolic syndrome in Korea has been re-
ported to be similar to that in Western populations. The 
most important factor contributing to the high prevalence 
of metabolic syndrome in Korea involves low serum HDL-
cholesterol levels. In the 2001 KNHANES, 36.3% of males 
had HDL-cholesterol < 40 mg/dL, and 58.5% of females 
had HDL-cholesterol < 50 mg/dL [15]. The NCEP criteria 
for reduced HDL-cholesterol might not be appropriate for 
Asian populations, and some studies have used a cutoff 
for reduced HDL-cholesterol of < 40 mg/dL for both sexes 
[27,28]. Indeed, HDL-cholesterol levels among Koreans 
are even lower than those of other East Asian populations 
[28-30] and show only a small sex difference (Table 5). 
However, the causes and effects of low HDL-cholesterol 
among Koreans remain unknown, and the modified cutoff 
points have not been used in Korean studies.
Methods of statistical analysis should be clearly de-
scribed in disease-prevalence studies because the method 
used also can affect prevalence estimates. First, inclusion 
and exclusion criteria for the analysis should be consid-
ered. In the 1998 and 2001 KNHANES, blood samples 
were drawn from all eligible participants with their fast-
ing hours recorded. However, in the 2005 KNHANES, 
participants who had fasted for less than 8 hours were re-
scheduled for a second visit. Among the participants aged 
20-79 years who completed health examinations, 14% in 
Table 3. Effects of sampling weights and exclusion criteria on the prevalence of metabolic syndrome
Sex Age
Prevalence estimation using all eligible subjects, 
%
Prevalence estimation excluding subjects not meeting fasting 











Male 20-29 400 15.0 (11.5-18.5) 16.0 (12.2-19.8) 292 16.1 (11.9-20.3) 17.2 (12.6-21.8)
30-39 624  27.1 (23.6-30.6) 26.9 (23.3-30.5) 508 25.2 (21.4-29.0) 25.5 (21.6-29.5)
40-49 546  32.8 (28.8-36.7) 32.2 (28.2-36.3) 421   32.1 (27.6-36.5) 31.3 (26.8-35.9)
50-59 362  37.6 (32.6-42.6) 37.3 (32.2-42.4) 294 35.7 (30.2-41.2) 35.5 (29.9-41.1)
60-69 288   42.0 (36.3-47.7) 40.3 (34.5-46.1) 240  42.1 (35.8-48.3) 40.4 (34.1-46.8)
70-79 129 36.4 (28.1-44.7) 37.0 (28.4-45.6) 104 37.5 (28.2-46.8) 38.5 (28.9-48.1)
Total 2,349  30.3 (28.5-32.2) 30.1 (28.2-32.0) 1,859 29.9 (27.8-31.9) 29.6 (27.4-31.7)
Female 20-29 548   7.7 (5.4-9.9) 7.7 (5.4-10.1) 409 7.3 (4.8-9.9) 7.5 (4.8-10.2)
30-39 834 18.7 (16.1-21.4) 19.1 (16.3-21.9) 629 18.3 (15.3-21.3) 18.7 (15.5-21.9)
40-49 722 28.5 (25.2-31.8) 28.4 (25.1-31.8) 573 29.3 (25.6-33.0) 29.3 (25.4-33.1)
50-59 453    51.0 (46.4-55.6) 50.7 (45.9-55.4) 369 50.9 (45.8-56.1) 50.8 (45.5-56.0)
60-69 377   66.0 (61.3-70.8) 65.4 (60.4-70.4) 315 66.0 (60.8-71.3) 65.5 (60.0-70.9)
70-79 226 65.0 (58.8-71.3) 64.7 (58.3-71.1) 183 65.0 (58.1-71.9) 64.9 (57.8-72.0)
Total 3,160   32.6 (31.0-34.3) 32.8 (31.1-34.5) 2,478 33.4 (31.6-35.3) 32.8 (30.9-34.7)
Metabolic syndrome was defined according to the revised NCEP criteria with modified waist circumference cutoff points (> 90/80 cm).
CI, confidence interval; NCEP, National Cholesterol Education Program-Adult Treatment Panel III.Kim HC and Kim Dj. Causes of different prevalence of metabolic syndrome     445
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1998 and 21% in 2001 had fasted for an insufficient period 
of time or were currently pregnant, but only 3% failed to 
meet these criteria (i.e., fasting and not pregnant) in 2005. 
Both insufficient fasting period and pregnancy can lead to 
overestimation of metabolic syndrome, but they had only 
minimal effects on the prevalence of metabolic syndrome 
in our analyses (Table 3). This might be attributed to the 
fact that a majority (71.3%) of insufficient fasting times 
fell between six to eight hours, and the pregnancy rate was 
low. However, these variables may influence the estimates 
for smaller subgroups, as both insufficient fasting and 
pregnancy rates depend on age and sex. Second, sampling 
weights used in some studies should be considered. The 
KNHANES applied unequal selection probabilities and 
assigned different sampling weights to each sample unit. 
Many, but not all, of the KNHANES studies considered 
the sampling weights to estimate the prevalence of meta-
bolic syndrome. Some studies did not consider sampling 
weights simply because estimating prevalence was not 
their primary objective, but even prevalence studies often 
have not reported whether sampling weights were consid-
ered [13,14]. In the present study, the sampling weights did 
not significantly affect the estimated prevalence of meta-
bolic syndrome. Sampling units and their weights in the 
KNHANES were related to geographic regions and resi-
dential types. Although socioeconomic factors have been 
associated with metabolic syndrome [18,31-33], regional 
differences in its prevalence may be too modest to affect 
national prevalence estimates. Adjustment for age must 
also be considered, as some studies have reported age-
adjusted prevalence [13-16].
Of the individual metabolic variables, triglyceride levels 
increased and HDL-cholesterol levels decreased between 
1998 and 2001, while others (waist circumference, blood 
pressure, and fasting glucose) remained relatively constant 
during the same period. The exceptionally high triglycer-
ide level in 2001 might have contributed to the increased 
prevalence of metabolic syndrome between 1998 and 
2001. Thus, we estimated the prevalence of metabolic syn-
drome using both absolute (150 mg/dL) and relative (75th 
percentile) cutoffs for determining elevated triglycerides. 
When we used the absolute criterion, the prevalence of 
metabolic syndrome increased significantly between 1998 
and 2001 and decreased between 2001 and 2005. How-
ever, when we used the relative criterion, no significant 
change was observed in males. In females, the prevalence 
of metabolic syndrome did not differ between 1998 and 
2001, but that in 2005 was lower than the levels in 1998 
and 2001. It is reasonable to hypothesize that the reports 
of the abrupt increase and decrease in metabolic syn-
drome during this short period resulted, at least in part, 
from non-standardized laboratory methods for measuring 




1998 2001 2005 1998 2001 2005
WC, cm 83 [77-89] 84 [78-89] 84 [78-90] 77 [71-84] 78 [71-85] 77 [71-84]
SBP, mmHg   124 [116-135]  122 [114-134]  119 [110-129]  118 [109-130]   115 [106-129]   110 [101-123]
DBP, mmHg 80 [73-88] 80 [72-87] 80 [73-87] 75 [69-82] 74 [68-81]  73 [68-80]
TG, mg/dL 122 [85-172] 133 [95-197] 121 [85-183]  95 [67-136] 102 [71-147]   90 [66-129]
HDLC, mg/dL  46 [39-55] 43 [37-50] 41 [36-48] 51 [43-59] 47 [41-55]  46 [40-53]
FBS, mg/dL   96 [88-106]   96 [88-105] 91 [85-98]  95 [87-104]   94 [88-103]  88 [83-94]
Metabolic 
syndrome, %
26.2 (24.6-27.9) 29.6 (27.4-31.7) 27.2 (25.1-29.4) 29.2 (27.7-30.7) 32.8 (30.9-34.7) 24.7 (22.9-26.5)




22.6 (21.0-24.1) 23.6 (21.7-25.6) 23.9 (21.8-25.9) 30.9 (29.3-32.4) 33.1 (31.2-35.0) 26.5 (24.7-28.4)
Reference p = 0.399 p = 0.319 Reference p = 0.075 p < 0.001
Values are presented as median [25th-75th percentiles] or prevalence (95% CI). 
Metabolic syndrome was defined according to the revised NCEP criteria with modified WC cutoff points (> 90/80 cm)
WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; HDLC, high-density lipoprotein 
cholesterol; FBS, fasting blood glucose; CI, confidence interval; NCEP, National Cholesterol Education Program-Adult Treatment Panel III.
aElevated TG was defined the sex-specific highest quartile in each year.446    The Korean journal of Internal Medicine Vol. 26, No. 4, December 2011
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triglycerides.
This study has some limitations. First, we did not assess 
all factors that could affect the prevalence of metabolic 
syndrome. For example, Kahn et al. [1] noted that the am-
biguity in definitions of individual metabolic abnormalities 
represented one of the limitations in the concept of meta-
bolic syndrome. Most studies have considered individuals 
receiving anti-hypertensive treatment as hypertensive; 
nonetheless, definitions of antihypertensive treatment 
might differ. The KNHANES included many different 
variables relating to the treatment of hypertension: known 
hypertension, physician-diagnosed hypertension, other-
wise-diagnosed hypertension, overall anti-hypertensive 
treatment, treatment within last two weeks, frequency 
of treatment, pharmacologic treatment, and non-phar-
macologic treatment. Thus, treated hypertension can be 
defined in many different ways, and the different defini-
tions may affect identification of people with high blood 
pressure. Although the same cutoff point is used, a man 
with waist circumference 90 cm would be considered cen-
trally obese in some studies [2,5,7,11,13,15,16] but normal 
in others [8-10,14]. However, these factors are unlikely to 
have a significant impact on studies, such as KNHANES, 
with large sample sizes. Second, the comparisons between 
years covered in this study might be inappropriate be-
cause our analyses were based primarily on three different 
cross-sectional surveys. Although the methodology of the 
KNHANES has been generally similar over time, changes 
in survey methods and participating institutions have also 
occurred. Third, this study compared different definitions 
of metabolic syndrome and individual metabolic abnor-
malities but could not suggest which definitions are appro-
priate for Korean populations.
In summary, the disparate reports of the prevalence of 
metabolic syndrome in Korea are due primarily to differ-
ing definitions of the syndrome and modified criteria for 
individual metabolic abnormalities. Non-standardized 
laboratory techniques also can affect estimates of the 
prevalence of metabolic syndrome. Different statistical 
methods and exclusion criteria, and ambiguous definitions 
of individual metabolic abnormalities may also affect such 
estimates. However, the effects of these factors on overall 
estimates of prevalence were minimal, at least in regard to 
the KNHANES. The absence of a standard definition for 
metabolic syndrome renders estimates and comparisons 
of the prevalence rate problematic. A consensual definition 
of metabolic syndrome in Korea is necessary for effective 
monitoring and management of the syndrome. Unfortu-
nately, insufficient prospective data are available for the 
development of a Korean-specific definition of metabolic 
syndrome. Thus, it is important to be aware of the po-
tential causes of different estimates when reporting and 
interpreting the prevalence of metabolic syndrome. At the 
same time, prospective studies are needed to define ap-
propriate cutoff points for each metabolic risk factor based 
on its predictive power.
Table 5. Mean values of metabolic variables in nationwide surveys conducted in East Asian nations
Variables

















Study year 2001 2000 2000-2001 2002
Age range 20-79 20-79 35-74 20-79
Age, yr   44 ± 0.3 44 ± 0.3 46 ± 0.3     46 ± 0.5   50 ± 0.2 50 ± 0.2 45 ± 0.3    44 ± 0.3
BMI, kg/m
2 23.6 ± 0.1 23.4 ± 0.1 23.4 ± 0.1 22.4 ± 0.1 23.1 ± 0.1 23.5 ± 0.2 24.3 ± 0.1 23.1 ± 0.1
WC, cm   84 ± 0.2   78 ± 0.2 84 ± 0.2     73 ± 0.3 80 ± 0.1 77 ± 0.1 84 ± 0.2    76 ± 0.2
SBP, mmHg 125 ± 0.4 119 ± 0.4 125 ± 0.4   120 ± 0.5 126 ± 0.3 124 ± 0.3 119 ± 0.3    113 ± 0.3
DBP, mmHg   80 ± 0.3 75 ± 0.2 76 ± 0.3     72 ± 0.3   80 ± 0.2 78 ± 0.2 78 ± 0.2    73 ± 0.2
TG, mg/dL 156 ± 2.0 120 ± 1.4 145 ± 3.0     92 ± 1.6 129 ± 1.8 127 ± 0.9 148 ± 1.6    115 ± 1.3
HDLC, mg/dL   44 ± 0.2   48 ± 0.2 55 ± 0.3     65 ± 0.4  51 ± 0.4 53 ± 0.4 51 ± 0.3    59 ± 0.3
FBS, mg/dL   98 ± 0.4 98 ± 0.3 98 ± 0.4     91 ± 0.4 98 ± 0.4 99 ± 0.4 96 ± 0.6    95 ± 0.5
Values are presented as mean ± standard error.
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; HDLC, 
high-density lipoprotein cholesterol; FBS, fasting blood glucose. Kim HC and Kim Dj. Causes of different prevalence of metabolic syndrome     447
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